Loading…
●Research use only — not for human or veterinary use
Also known as Body Protection Compound-157
A synthetic pentadecapeptide studied in cellular and tissue-signaling research. Supplied as a documented reference standard.
BPC-157 is a synthetic pentadecapeptide derived from a sequence identified in a gastric protein. In the research literature it is studied in the context of cytoprotection, angiogenesis signaling, and growth-factor pathway modulation in cell and tissue models. It is investigated as a reference tool for these pathways rather than for any applied outcome.
It is a 15-residue peptide (sequence GEPPPGKPADDAGLV) with a molecular weight of ~1,419.5 g/mol. As a short, unmodified peptide it is well suited to standard reversed-phase analysis and solid-phase synthesis.
BPC-157 is studied alongside other tissue & cellular signaling references. It is frequently examined together with TB-500 (thymosin β4), and the closely related tripeptide KPV sits in the same broad signaling area.
Supplied lyophilised, it follows the standard handling profile for short peptides — see lyophilised peptide stability and, once reconstituted, freeze-thaw degradation.
Each lot is characterised by HPLC purity and mass-spec identity, with salt content covered by counter-ion analysis. The combined figures appear on the lot Certificate of Analysis.
All references to BPC-157 here describe in-vitro and pre-clinical research. The compound is supplied strictly as a research-use-only reference standard and is not for human or veterinary use.
Store lyophilised at -20 °C; reconstituted material at 2–8 °C within the analytical window.
Reconstituted purity tracked by HPLC; aliquot to manage freeze-thaw exposure.
Research use only — All products and content are intended strictly for in-vitro laboratory research and analytical use. Not for human or veterinary use, not for consumption, and not for any diagnostic or therapeutic purpose.